A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Recruiting

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(281 sites)

United States

Chandler Clinical Trials, LLC, Chandler, Arizona

Gilbert Neurology Partners - PLLC - Avacare, Gilbert, Arizona

Banner Alzheimer's Institute, Phoenix, Arizona

Scottsdale Clinical Trials, Scottsdale, Arizona

Advanced Research Center, Inc., Anaheim, California